Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia

Christie M. Ballantyne(Baylor College of Medicine), Enrico P. Veltri(United States Nuclear Regulatory Commission), Alexandre LeBeaut(United States Nuclear Regulatory Commission), Lorenzo Melani(United States Nuclear Regulatory Commission), Steven Sun(United States Nuclear Regulatory Commission), Philip T. Sager(United States Nuclear Regulatory Commission), A Notarbartoló(United States Nuclear Regulatory Commission), John Houri(United States Nuclear Regulatory Commission), Leslie Lipka(United States Nuclear Regulatory Commission), Ramachandran Suresh(United States Nuclear Regulatory Commission)
Circulation
May 19, 2003
10.1161/01.cir.0000068312.21969.c8
Cited by 682

Related Papers

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis
|JAMA|2006|2k